Related Experiment Videos
Current management of lower genital tract preneoplasia
The Medical Journal of Australia
|September 16, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2003
The Polarprobe--emerging technology for cervical cancer screening.
Annals of the Academy of Medicine, Singapore·1999
Colposcopic differentiation of abnormalities arising in the transformation zone.
Obstetrics and gynecology clinics of North America·1993
Percutaneous urinary diversion in gynecologic oncology.
Gynecologic oncology·1991
Not Gone but Often Forgotten: Action Needed to Address Tuberculosis in Aboriginal and Torres Strait Islander Communities.
The Medical journal of Australia·2026
Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.
The Medical journal of Australia·2026
Time for an Update: The Currency of Clinical Guidelines in Australia-A Cross-Sectional Analysis.
The Medical journal of Australia·2026
Forty Years in the Making: Reporting on the Co-Creation of a National Roadmap for Birthing on Country Services for the Best Start to Life.
The Medical journal of Australia·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026